Jennifer Miller

Bioethics International, headed by former Lab Fellow, Jennifer Miller, awarded $3.6 million grant from the Laura and John Arnold Foundation

June 1, 2016

The Laura and John Arnold Foundation announced a $3.6 million grant to Bioethics International to increase clinical trial transparency for FDA approved drugs and interventions. The grant will allow the nonprofit group to expand its Good Pharma Scorecard, which is focused on increasing clinical trial transparency and integrity so patients can better access medicines. Former...

Read more about Bioethics International, headed by former Lab Fellow, Jennifer Miller, awarded $3.6 million grant from the Laura and John Arnold Foundation

Former Lab Fellow Jennifer Miller's Good Pharma Scorecard

November 12, 2015

In a research article published today in BMJ Open, former Lab Fellow Jennifer E. Miller, Faculty Associate David Korn, and Joseph S. Ross examine clinical trial results disclosure by large pharmaceutical companies and conclude that it falls below legal and ethical standards. The article also introduces an annual transparency scorecard which audits...

Read more about Former Lab Fellow Jennifer Miller's Good Pharma Scorecard

Jennifer Miller - Bioethical Standards for the Pharmaceutical Industry? Concerns & a Reform Strategy

The March 12, 2014, Lab seminar was led by Edmond J. Safra Lab Fellow, Jennifer E. Miller. During her second fellowship year, Miller has continued to explore the possibility of addressing prominent ethical concerns and trust gaps in the pharmaceutical industry through a number of reform strategies, particularly policy amendments and a third party rating system. Her seminar presentation, titled, “Bioethical Standards for the Pharmaceutical Industry? Concerns & a...

Read more about Jennifer Miller - Bioethical Standards for the Pharmaceutical Industry? Concerns & a Reform Strategy

Jennifer Miller — Ethical Standards in the Pharma Industry? Industry Perspectives & Strategies for Trustworthy Reform

The November 14, 2012, Lab seminar was led by Edmond J. Safra Lab Fellow, Jennifer Miller. During her fellowship, Jennifer will explore the possibility of addressing prominent ethical concerns and trust gaps in the pharmaceutical industry through a number of reform strategies, particularly policy amendments and a third party ethics accreditation or rating system.

This will involve first mapping the prominent bioethical concerns challenging the industry. Second,...

Read more about Jennifer Miller — Ethical Standards in the Pharma Industry? Industry Perspectives & Strategies for Trustworthy Reform

A Good Housekeeping Seal for Bioethics: Could It Improve Trust and Ethics in the Pharmaceutical Industry?

by Jennifer E. Miller

The public’s “negative view of the pharmaceutical industry is a major problem… (and there is) no shortage of “experts” with solutions on how to fix the problem. Unfortunately, many of the proposals are shockingly naïve and without merit,” grumbles John LaMattina, former President of Pfizer Global R&D. In response to LaMattina’s challenge for outsiders to develop more realistic reform strategies, this blog post proposes the introduction of an ethics accreditation system, akin to a Good Housekeeping Seal, as a practical means for the industry to credibly improve its ethics and restore its broken image.

... Read more about A Good Housekeeping Seal for Bioethics: Could It Improve Trust and Ethics in the Pharmaceutical Industry?